Treatment of patients with chronic hepatitis C and normal ALT levels.
about
Histological and clinical characteristics of patients with chronic hepatitis C and persistently normal alanine aminotransferase levelsDetection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury.Dysfunction of Immune Systems and Host Genetic Factors in Hepatitis C Virus Infection with Persistent Normal ALT.Plasma sphingolipids as potential indicators of hepatic necroinflammation in patients with chronic hepatitis C and normal alanine aminotransferase level.Treating viral hepatitis C: efficacy, side effects, and complications.Review article: management of patients with chronic hepatitis C virus infection and "normal" alanine aminotransferase activity.Clamp-crush technique vs. radiofrequency-assisted liver resection for primary and metastatic liver neoplasmsHepatitis C virus mediated chronic inflammation and tumorigenesis in the humanised immune system and liver mouse model.Down regulation of TRIF, TLR3, and MAVS in HCV infected liver correlates with the outcome of infection.Risk factors for hepatocellular carcinoma in hepatitis C patients with normal alanine aminotransferase treated with pegylated interferon and ribavirin.Lack of clinical and histological progression of chronic hepatitis C in individuals with true persistently normal ALT: the result of a 17-year follow-up.Patients with chronic hepatitis C and normal transaminases.Hepatitis C infection in Alaska Natives with persistently normal, persistently elevated or fluctuating alanine aminotransferase levels.Pilot study of interferon-alpha and ribavirin treatment in patients with chronic hepatitis C and normal transaminase values.Progressive hepatic fibrosis in healthy carriers of hepatitis C virus with a transaminase breakthrough.Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels: a matched case-control study.Impact of pegylated interferon and ribavirin on morbidity and mortality in patients with chronic hepatitis C and normal aminotransferases in France.The economics of treating chronic hepatitis C patients with peginterferon alpha-2a (40 kDa) plus ribavirin presenting with persistently normal aminotransferase.Elevated frequency and function of regulatory T cells in patients with active chronic hepatitis C.Interferon alfa-2b [correction of alpha-2b]and ribavirin for patients with chronic hepatitis C and normal ALT.Hepatitis C virus with normal transaminase levels.Upper limit of normal serum alanine and aspartate aminotransferase levels in Korea.Incidence of hepatocellular carcinoma in HCV-infected patients with normal alanine aminotransferase levels categorized by Japanese treatment guidelines.The management of chronic viral hepatitis: A Canadian consensus conference 2004.
P2860
Q33660486-2FBC6F82-834E-4E91-85ED-5937E40E71D1Q34359266-CBC6662E-145D-4C2F-9656-4AD8580547FBQ35094287-CF67192E-1418-43D1-8577-2EF9F87D7F59Q35149163-7283FD77-DDF1-404C-BF2B-32001AB37D3BQ36564615-B4B8BDC6-A045-4D74-895F-280814BE2985Q36609890-AA3152A1-AA56-4288-9884-996E9207AAAFQ37305612-7FD84739-F618-4B33-8762-D0635A5E3C43Q40050887-8D8F11D8-1447-464F-9B3A-EDD951ACE065Q40211217-5443C113-5CFF-465C-8B47-38C6335CBD67Q42225908-69634196-ACDF-44CE-871A-51BC279A384EQ42271121-531D5B52-C9A7-438B-850D-7468BD87721FQ42996773-E0B98143-3C9B-4980-A351-B5E97460A5F5Q43001259-9A875E7F-6C39-4B9B-BE4B-0B2397429354Q43031818-F5D707D3-CBBE-4242-BB10-161AB245933BQ43036622-5B74E5B5-4997-49FB-9D40-14B308EC31D7Q43039891-EDE6217F-FB7A-4C52-A2A3-B7B1195C75E9Q43292657-12BFCDB0-0FB8-4585-999F-47AE65024F77Q43707240-65156CB7-03A6-46F4-BDEF-808E3130BDD5Q44433005-21DC2F54-1E05-46FA-9E5B-17E962E58C4FQ45031709-EB1F0D72-77EF-4C35-87D1-DD2E4D2E4784Q45400335-967A2883-94B2-46CC-B324-6572B3E083BEQ50513280-7394ED82-BA02-474B-A47D-D15324E8B94EQ50551090-1882F91D-5142-4FF9-B0F4-F2888AB05D37Q55428306-292322FF-7723-4CFD-ACDC-EBBE3554E9C2
P2860
Treatment of patients with chronic hepatitis C and normal ALT levels.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Treatment of patients with chronic hepatitis C and normal ALT levels.
@ast
Treatment of patients with chronic hepatitis C and normal ALT levels.
@en
type
label
Treatment of patients with chronic hepatitis C and normal ALT levels.
@ast
Treatment of patients with chronic hepatitis C and normal ALT levels.
@en
prefLabel
Treatment of patients with chronic hepatitis C and normal ALT levels.
@ast
Treatment of patients with chronic hepatitis C and normal ALT levels.
@en
P1476
Treatment of patients with chronic hepatitis C and normal ALT levels.
@en
P2093
Tassopoulos NC
P304
P356
10.1016/S0168-8278(99)80400-0
P478
31 Suppl 1
P577
1999-01-01T00:00:00Z